Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Impact of patient characteristics and treatment patterns on outcomes in potentially resectable pancreatic cancer (PC).
Authors
Andrew Steinmetz
University of Cincinnati College of Medicine, Cincinnati, OH;
Andrew Steinmetz , Sameer H. Patel , Gregory C. Wilson , Jeffrey J. Sussman , Olugbenga Olanrele Olowokure , Jordan Kharofa , Syed A. Ahmad , Davendra Sohal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Clinical Trial Registration Number
Add this
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 681)
DOI
10.1200/JCO.2023.41.4_suppl.681
Abstract #
681
Poster Bd #
J6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO).
First Author: Fergus Keane
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical therapeutic effects of neoadjuvant chemotherapy in resectable pancreatic cancer.
First Author: Masaaki Murakawa
Poster
2020 Gastrointestinal Cancers Symposium
Real-world patterns of care among patients with metastatic pancreatic cancer (mPC).
First Author: Eileen Mary O'Reilly
Poster
2020 Gastrointestinal Cancers Symposium
Outcomes and efficacy of neoadjuvant chemoradiation versus chemotherapy in localized pancreatic cancer.
First Author: Asmita Chopra